Targeted gene modification mediated by single-stranded oligonucleotides (SSOs) holds great potential for widespread use in a number of biological and biomedical fields, including functional genomics and gene therapy. By using this approach, specific genetic changes have been created in a number of prokaryotic and eukaryotic systems. In mammalian cells, the precise mechanism of SSO-mediated chromosome alteration remains to be established, and there have been problems in obtaining reproducible targeting efficiencies. It has previously been suggested that the chromatin structure, which changes throughout the cell cycle, may be a key factor underlying these variations in efficiency. This hypothesis prompted us to systematically investigate SSO-mediated gene repair at various phases of the cell cycle in a mammalian cell line. We found that the efficiency of SSO-mediated gene repair was elevated by Ϸ10-fold in thymidine-treated S-phase cells. The increase in repair frequency correlated positively with the duration of SSO͞thymidine coincubation with host cells after transfection. We supply evidence suggesting that these increased repair frequencies arise from a thymidine-induced slowdown of replication fork progression. Our studies provide fresh insight into the mechanism of SSO-mediated gene repair in mammalian cells and demonstrate how its efficiency may be reliably and substantially increased.single-stranded oligonucleotide ͉ targeted gene repair ͉ thymidine D eveloped over the past few years, targeted genetic modification mediated by oligonucleotides promises to be an invaluable technique for use in functional genomic studies and may even form the basis of future gene therapy procedures (1-3). This approach is applicable for the specific alteration of short stretches of DNA to create deletions, short insertions, and point mutations (4, 5). Therefore, it is ideally suited for the study of single-nucleotide polymorphisms (SNPs) in model organisms such as mice and ultimately may be used for the treatment of diseases caused by small DNA alterations (6, 7).Studies have shown that both chimeric RNA͞DNA oligonucleotides (RDOs) and single-stranded DNA oligonucleotides (SSOs), which may contain a number of unnatural or ''modified'' linkages or bases, can introduce targeted genetic alterations in bacteria, fungi, and mammalian cells (8 -13). For RDOmediated repair, in which it is the DNA moiety that directs the genetic conversion event (14), there have been large variations in targeting efficiencies reported and problems with reproducibility (15). Compared with RDOs, SSOs appear to have the greater potential for development, because they have better stability, and are more easily synthesized, modified, and purified. SSOs also exhibit reliably higher in vivo targeting efficiencies than RDOs (16,17).To expedite the optimization of conditions for SSO-mediated repair, it is first vital to establish the exact mechanism(s). Analogous to the situation for RDOs, a two-step mechanism has been proposed, which involves the following st...